...
首页> 外文期刊>The journal of immunology >Central Role for Endothelial Human Deneddylase-1/SENP8 in Fine-Tuning the Vascular Inflammatory Response
【24h】

Central Role for Endothelial Human Deneddylase-1/SENP8 in Fine-Tuning the Vascular Inflammatory Response

机译:内皮人类deneddylase-1 / SENP8在微调血管炎症反应中的核心作用。

获取原文
   

获取外文期刊封面封底 >>

       

摘要

A deeper understanding of the mechanisms that control responses to inflammation is critical to the development of effective therapies. We sought to define the most proximal regulators of the Cullin (Cul)-RING ligases, which play a central role in the stabilization of NF-κB and hypoxia-inducible factor (HIF). In these studies, we identify the human deneddylase-1 (SENP8) as a key regulator of Cul neddylation response in vitro and in vivo. Using human microvascular endothelial cells (HMECs), we examined inflammatory responses to LPS or TNF-α by assessing Cul neddylation status, NF-κB and HIF-1α stabilization, and inflammatory cytokine secretion. HMECs with an intact neddylation pathway showed a time-dependent induction of Cul-1 neddylation, nuclear translocation of NF-κB, stabilization of HIF-1α, and increased NF-κB/HIF-α promoter activity in response to LPS. HMECs lacking SENP8 were unable to neddylate Cul-1 and subsequently were unable to activate NF-κB or HIF-1α. Pharmacological targeting of neddylation (MLN4924) significantly abrogated NF-κB responses, induced HIF-1α promoter activity, and reduced secretion of TNF-α–elicited proinflammatory cytokines. MLN4924 stabilized HIF and abrogated proinflammatory responses while maintaining anti-inflammatory IL-10 responses in vivo following LPS administration. These studies identify SENP8 as a proximal regulator of Cul neddylation and provide an important role for SENP8 in fine-tuning the inflammatory response. Moreover, our findings provide feasibility for therapeutic targeting of the Culs during inflammation.
机译:对控制炎症反应机制的更深入了解对于开发有效疗法至关重要。我们试图定义最接近的Cullin(Cul)-RING连接酶调节剂,其在NF-κB和缺氧诱导因子(HIF)稳定中起着核心作用。在这些研究中,我们确定了人类denddylase-1(SENP8)是体外和体内Cul联氨反应的关键调节剂。我们使用人类微血管内皮细胞(HMEC),通过评估Cul的神经元化状态,NF-κB和HIF-1α的稳定性以及炎性细胞因子的分泌,检查了对LPS或TNF-α的炎症反应。 HMECs的完整的腺苷酸化途径表现出时间依赖性的诱导Cul-1腺苷化,NF-κB的核易位,HIF-1α的稳定化以及对LPS响应的NF-κB/HIF-α启动子活性的增加。缺乏SENP8的HMECs不能使Cul-1交联,随后不能激活NF-κB或HIF-1α。药理学上的针对腺苷酸化作用(MLN4924)消除了NF-κB反应,诱导了HIF-1α启动子活性,并减少了TNF-α引起的促炎细胞因子的分泌。 MLN4924在LPS给药后可在体内维持HIF并消除促炎反应,同时在体内保持抗炎IL-10反应。这些研究将SENP8识别为Cul融合的近端调节剂,并为SENP8在微调炎症反应中发挥重要作用。此外,我们的发现为炎症过程中靶向Culs提供了可行性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号